Home
Drugs & Trials
Beacon ADC
Beacon Bispecific
Beacon Cancer Vaccine
Beacon Cell Therapy
Beacon Checkpoint
Beacon Cytokine
Beacon DDR
Beacon Gene Therapy
Beacon Immune Tolerance
Beacon Microbiome
Beacon Oncolytic Viruses
Beacon RNA
Beacon TPD
Biomarkers & Assays
Lung Cancer
About
News
Events
Resources
Contact
Login
Site Map
Content Types
Posts
‘Breaking the mold with RNA—a “RNAissance” of life science’ – npj Genomic Medicine
Beacon maps over 2300 lung cancer biomarkers in new global database – PBI Forum
New day for antibody-drug conjugates – Chemical & Engineering News
What makes a good antibody–drug conjugate? – Martin De Cecco, Daniel N. Galbraith & Lisa L. McDermottt
Beacon Targeted Therapies announces the launch of Beacon Oncolytic Viruses
Cell Therapy 2.0
Overcoming Challenges in the Development of Anticancer ADCs
Immuno-oncology cell therapies: commercial considerations and strategies for the new decade
Beacon Targeted Therapies announces the launch of Beacon Gene Therapy
Frontiers in Oncology – Perspective: Designing T-Cell Engagers With Better Therapeutic Windows
Hot Topics at CAR-TCR 2020
Assessment of Clinical Activity of PD-1 Checkpoint Inhibitor Combination Therapies Reported in Clinical Trials
TCR Therapies Summit 2020 Magazine
Drug developers take fresh aim at ‘guided-missile’ cancer drugs
CAR-TCR Europe Summit 2020 Magazine
World ADC London 2020 Magazine
Innate Killer Summit 2020 Magazine
From Mylotarg to Polivy: Ebbs and flows, successes and woes of ADCs
Trends & Forecasts – Tenacious ADCs
World ADC San Diego Magazine 2019
Biomarkers for Checkpoint Inhibition and Their Clinical Utility – Timothy James Fabisiak, B.A.
Bispecific antibodies: a mechanistic review of the pipeline Aran F. Labrijn, Maarten L. Janmaat, Janice M. Reichert & Paul W. H. I. Parren
Beacon Targeted Therapies Launches Beacon Adoptive Cell
The Evolving Shape of the ADC Market: The Widening Application of ADCs and Manufacturing Improvements Meeting Demand – Charlie Johnson, CEO of ADC Bio, adcbio.com
Antibodies to watch in 2019 – Hélène Kaplon & Janice M. Reichert
Pages
Biomarkers & Assays
Webinar Resources
Internal Comms
Our data charter
FAQS
Advanced Keyword Searches
News
Solutions
Request a demo
About
Contact
Events
Who’s it for?
Privacy Policy
Resource Center
Site Map
Terms & Conditions
Home
Solutions
Beacon Oncology
Beacon Cell Therapy
Biomarkers & Assays – Lung Cancer
Beacon Immune Tolerance
Beacon Microbiome
Beacon RNA
Beacon Cytokine
Beacon Cancer Vaccine
Beacon TPD
Beacon DDR
Beacon Oncolytic Viruses
Beacon Gene Therapy
Beacon Checkpoint
Beacon Bispecific
Beacon ADC
Events
9th CAR-TCR Summit 2024
4th Induced Proximity-Based Drug Discovery Summit 2024
9th Microbiome Movement Drug Development Summit 2024
4th Oligonucleotides for CNS Summit 2024
ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summit 2024
15th World Bispecific Summit 2024
3rd Cell Therapy Analytical Development Summit Europe
3rd World ADC Asia 2024
6th Annual Allogeneic Cell Therapies Summit 2024
4th Next Generation Gene Therapy Vectors Summit 2024
3rd Annual LNP Formulation & Process Development Summit
7th International Neoantigen Summit 2024
5th Cytokine-Based Drug Development Summit 2024
6th Cell Engager Summit 2024
6th Treg Directed Therapies Summit 2024
4th TPD Summit Europe 2024
8th Liquid Biopsy for Precision Oncology Summit
9th Innate Killer Summit
7th Antigen-Specific Immune Tolerance Drug Development Summit 2024
14th World ADC London 2024
2nd Molecular Glue Drug Development Summit
7th CAR-TCR Europe Summit 2024
3rd mRNA-Based Therapeutics Summit Europe 2024
8th Microbiome Movement – Drug Development Europe 2024
7th DDR Inhibitors Summit 2024
2nd Cell Therapy for Autoimmune Disease Summit
14th World Bispecifics Summit 2023
8th Oncolytic Virotherapy Summit 2023
6th Targeted Protein Degradation Summit
mRNA Cancer Vaccines Summit 2023
13th World Clinical Biomarkers & CDx Summit
8th CAR-TCR Summit 2023
4th Annual Gamma Delta T Therapies Summit 2023
14th World ADC San Diego 2023
3rd mRNA-Based Therapeutics Summit
5th Gene Therapy for Neurological Disorders Summit 2023
8th Microbiome Movement – Drug Development Summit
5th Annual Allogeneic Cell Therapies Summit
5th Treg Summit
4th STING & TLR Targeting Therapies Summit
4th Cytokine-Based Drug Development Summit
2nd LNP Formulation & Process Development Summit
5th Cell Engager Summit
6th Neoantigen Summit Europe
Webinars
Novel Drug Conjugates and Clinical Success: An In-Depth Analysis of Emerging ADCs
Webinar – Exploring Allogeneic Cell Therapies: Pioneering Advantages and Recent Innovations
Webinar – Harnessing STING & TLR: Current Developments, Clinical Trials, and Key Players in the Landscape
Webinar – Inflammatory Bowel Disease: A Comprehensive Analysis of Drug and Market Trends
Webinar – Breaking Down AACR: A Comprehensive Review of DDR-Related Abstracts
Webinar – Navigating the Liquid Biopsy Landscape and the Role of ctDNA in Lung Cancer Research
Webinar – Decoding the Bivalent Degrader Landscape: Novel PROTACs, Developer Trends, and Future Innovations
Webinar – Exploring the Synergy of ADCs in Combination with Checkpoints: A Comprehensive Review
Webinar – The ADC Boom: Navigating the Expansive Landscape of Antibody-Drug Conjugates
Webinar – The Future of Cell Therapies: An In-Depth Analysis of the 2023 Commercial and Research Landscape
Webinar – Unlocking the Value of Microbiome-Targeting Therapeutics in Combating Infectious Diseases
Webinar – Bispecific Antibodies and Immune Checkpoint Modulators: A H1 Landscape Analysis
Webinar – Realizing the Full Potential within the RNA and Gene Therapy Landscapes: 2023 So Far
Webinar – Examining the Cytokine-Based Drug Development Landscape: Interleukins and Beyond
Webinar – T Cell Therapies: The Road Ahead for Addressing Autoimmune Indications
Webinar – The TPD Disease Landscape: Oncology vs. Non-Oncology
Webinar – Gene Therapy: Optimizing the Safety of Viral Vectors
Webinar – The DDR Landscape: The Past, Present & Future
Webinar – Landscape Analysis of Neoantigen Targeting Cancer Vaccines
Webinar – Three Generations of DDR Therapeutics
Infographics
H1 2024 Immune Tolerance Landscape Review
The 2024 DDR H1 Landscape Review
H1 2024 Bispecific Landscape Review
H1 2024 RNA Landscape Review
H1 2024 Gene Therapy Landscape Review
H1 2024 Checkpoint Landscape Review
H1 2024 ADC Landscape Review
H1 2024 Cell Therapy Landscape Review
H1 2024 Lung Cancer Landscape Review
Unlocking the Potential of Bispecific ADCs
Beacon TPD: Induced Proximity Landscape Review 2024
ASCO 2024: Checkpoint Highlights
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
ASCO 2024: Cytokine Highlights
ASCO 2024: ADC Highlights
ASCO 2024: Bispecific Highlights
Beacon Immune Tolerance: 2024 EULAR Annual Meeting Abstracts
Beacon TPD: ASCO Post-Conference Report 2024
Beacon DDR: ASCO Post-Conference Report 2024
Unlock the Future of Advanced Therapies: Insights from the ASGCT 2024 Annual Meeting
Microbiome: US Market and LBP Development
Beacon Oncolytic Viruses: 2024 ASCO Annual Meeting Abstracts
Beacon Cancer Vaccine: 2024 ASCO Annual Meeting Abstracts
Beacon Cell Therapy: 2024 ASGCT Annual Meeting Abstracts
Beacon Gene Therapy: 2024 ASGCT Annual Meeting Abstracts
Microbiome: Drug Development in Asia Infographic
Antibodies & Biologics Landscape Reviews
Beacon DDR: AACR Post-Conference Report 2024
TPD: AACR Post-Conference Report 2024
Beacon RNA: AACR Post-Conference Report 2024
Charting the Course: Trends and Challenges in Early-Stage Cytokine-Based Drug Development Commercialization
2023年抗体偶联药物研发格局回顾性报告
Beacon DDR: AACR Pre-Conference Planner 2024
The 2023 Checkpoint Landscape Review
The 2023 Bispecific Landscape Review
The 2023 DDR Landscape Review
The 2023 ADC Landscape Review
The 2023 Cytokine Landscape Review
The 2023 TPD Landscape Review
The 2023 Lung Cancer, Biomarkers & Assays Landscape Review
2023 Gene Therapy Landscape Review
The 2023 RNA Landscape Review
2023 Cell Therapy Landscape Review
The 2023 Microbiome Landscape Review
2023 Immune Tolerance Landscape Review
Global Commercial Insights From the Bispecific and Multispecific Market
2023 Oncolytic Viruses Landscape Review
2023 Cancer Vaccine Landscape Review
The Rise of ADCs and Novel Drug Conjugates in Asia
Beacon Checkpoint: PD-L1: An Endless Classic or Passing Fancy?
Beacon Cell Therapy: ASH 2023 Conference Coverage
Liquid Biopsy Assays For ctDNA Detection Infographic
Beacon DDR: AACR-NCI-EORTC Post-Conference Report 2023
Beacon Gene Therapy: 2023 ASH Annual Meeting Abstracts
Monoclonal Antibodies (mAbs) Unveiled: A Comprehensive Review of the Landscape in Immune-Mediated Diseases Report 2023
Beacon TPD: ASH Conference Coverage 2023
RNA SITC Post-Conference Report 2023
Infographic 2023 Oncolytic Viruses ESMO Abstracts Analysis
The Rise of Bispecific Combination Trials Infographic
Beacon DDR: ESMO Post-Conference Report 2023
Cytokine: ESMO Congress 2023 Abstracts
Checkpoint: ESMO Congress 2023 Abstracts
Infographic 2023 Cancer Vaccine ESMO Abstracts Analysis
Beacon TPD: Next Generation Degraders Infographic
Editing Technologies Report 2023
The Checkpoint Disease Landscape: Exploring the Top Cancer Indications
The Preclinical Cytokine Review: An Analysis of the Latest Data
The Oligonucleotide Landscape Digest
SITC 2023 Cancer Vaccine Annual Meeting Abstracts
SITC 2023 Oncolytic Viruses Annual Meeting Abstracts
Allergies Report 2023
SITC 2023 Cell Therapy Annual Meeting Abstracts
Infographic 2023 Unlocking the Potential of mRNA Cancer Vaccines
The DDR Combination Therapies Infographic
‘A Landscape Review Of Lung Cancer’ Presentation
The 2023 H1 RNA Landscape Review
The H1 2023 Cytokine Landscape Review
H1 2023 Oncolytic Viruses Landscape Review
The H1 2023 DDR Landscape Review
H1 2023 Cancer Vaccine Landscape Review
The H1 2023 ADC Landscape Review
The H1 2023 Checkpoint Landscape Review
The H1 2023 Bispecific Landscape Review
The H1 2023 Microbiome Landscape Review
The 2023 H1 TPD Landscape Review
H1 2023 Cell Therapy Landscape Review
H1 2023 Gene Therapy Landscape Review
H1 2023 Immune Tolerance Landscape Review
Cancer Vaccine: Exploring Human Papillomavirus Infographic
ADC Preclinical Development: Where are we in 2023?
Gene Therapy: Lysosomal Storage Diseases – A Comprehensive Overview
Report 2023 Oncolytic Viruses Monotherapies vs Combinations
Checkpoint: The Adenosine-Pathway Clinical Trial Landscape
Bispecific: Landscape Review of Checkpoint-Targeting Bispecifics
TPD: ASCO 2023 Infographic
Microbiome: Milestones Infographic
Adoptive Cell: ASCO Annual Meeting 2023 Abstracts
Cytokine: ASCO Annual Meeting 2023 Abstracts
Bispecific: ASCO Annual Meeting 2023 Abstracts
ADC: ASCO Annual Meeting 2023 Abstracts
Oncolytic Viruses ASCO Post-Conference Report 2023
Cancer Vaccine ASCO Post-Conference Report 2023
AACR 2023: ADC Highlights and Insights
Cytokine & Adoptive Cell: Cytokine-Armored Cell Therapies
Checkpoint: ASCO Annual Meeting 2023 Abstracts
RNA: mRNA-Based Therapeutics Infographic
Oncolytic Viruses: ASGCT Annual Meeting 2023 Abstracts
Adoptive Cell: ASGCT Annual Meeting 2023 Abstracts
Gene Therapy: ASGCT Annual Meeting 2023 Abstracts
Cancer Vaccine Infographic 2023
Microbiome: Preclinical Models Infographic
Cytokine: AACR Annual Meeting 2023 Abstracts
ADC: AACR Annual Meeting 2023 Abstracts
Checkpoint: AACR Annual Meeting 2023 Abstracts
Bispecific: AACR Annual Meeting 2023 Abstracts
Oncolytic Viruses: AACR Annual Meeting 2023 Abstracts
Cancer Vaccine: AACR Annual Meeting 2023 Abstracts
Adoptive Cell: AACR Annual Meeting 2023 Abstracts
The 2022 Cytokine Landscape Review
The 2022 Checkpoint Landscape Review
The 2022 ADC Landscape Review
The 2022 Bispecific Landscape Review
The 2022 TPD Landscape Review
The 2022 Cancer Vaccine Landscape Review
The 2022 Oncolytic Viruses Landscape Review
The 2022 Adoptive Cell Landscape Review
TPD – The Molecular Glue Landscape: A Review
The 2022 Gene Therapy Landscape Review
Checkpoint: The TIGIT Axis Targeted Cancer Clinical Trial Landscape
Cytokine: A Spotlight on the TGF-β Cancer Clinical Trial Landscape
Beacon Gene Therapy – The Eye Disorder Landscape
Cancer Vaccine Infographic 2022
Microbiome: GI and Metabolic Diseases Infographic
Beacon Gene Therapy – Clinical Holds in the AAV Space
Checkpoint: Mid-Year Landscape Review 2022
ADC: Mid-Year Landscape Review 2022
Oncolytic Viruses: Mid-Year Landscape Review 2022
Cancer Vaccine: Mid-Year Landscape Review 2022
Gene Therapy: Mid-Year Landscape Review 2022
Adoptive Cell: Mid-Year Landscape Review 2022
4-1BB Landscape Review: Shift Towards a Bispecific Therapeutics Approach
Oncolytic Viruses – Vaccinia Virus Analysis
Adoptive Cell – Manufacturing Challenges & Considerations for Allogeneic Cell Therapy
Gene Therapy AAV Durability Report
Archives
Categories
ADC
Advanced Therapies Webinar
Antibodies and Biologics Webinar
Biomarkers & Assays
Bispecific
Cancer Vaccine
Cell Therapy
Checkpoint
Cytokine
DDR
Gene Therapy
Immune Tolerance
Landscape - Antibodies
Landscape - Cell/Gene/RNA
Landscape - SM/Precision
Lung Cancer
Microbiome
Oncolytic Viruses
Recent Content
Report
Report
RNA
Small Molecules Webinar
TPD
Uncategorized
Webinar
Home
Drugs & Trials
Beacon ADC
Beacon Bispecific
Beacon Cancer Vaccine
Beacon Cell Therapy
Beacon Checkpoint
Beacon Cytokine
Beacon DDR
Beacon Gene Therapy
Beacon Immune Tolerance
Beacon Microbiome
Beacon Oncolytic Viruses
Beacon RNA
Beacon TPD
Biomarkers & Assays
Lung Cancer
About
News
Events
Resources
Contact
Login
This is the brochure-popup
This is the contact us popup